COVID-19FinancialHospitals

AHA sends letter to HHS requesting additional emergency funding

June 2, 2020 / Jeff Lagasse, Associate Editor

The U.S. Department of Health and Human Services has doled out emergency funding to hospitals and health systems to help hospitals with support and resources during the COVID-19 pandemic, but the American Hospital Association considers those funds a first step — and today, the AHA sent a letter to HHS requesting more.

The additional funds that are required are “substantial,” according to the AHA — about $50 billion in total — and should be distributed to hospitals and health systems in an expedited manner using a phased approach.

The AHA cites numerous state and local orders decreeing that many elective procedures remain cancelled, as well as many Americans’ voluntary postponement of needed care. COVID-19 treatment has resulted in skyrocketing demand for medical equipment and supplies, which in turn have increased costs.

WHAT’S THE IMPACT

To quantify that, AHA estimated a four-month financial impact of more than $202 billion in losses for hospitals and health systems, averaging more than $50 billion per month. The organization said all hospitals need additional funds, but in particular the “hot spot” hospitals and those serving high numbers of Medicaid and uninsured patients.

READ THE REST HERE

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button
Close